Related Experiment Videos

Differences associated with age, transfer status, and insurance coverage in end-of-life hospital care for children

R N Caskey1, M M Davis

  • 1Section of General Internal Medicine and General Pediatrics, University of Chicago, Chicago, Illinois, USA. rcaskey@uic.edu

Insights

Hospitalized children, especially infants and those transferred, face higher mortality risks. Uninsured children may experience higher mortality despite lower hospital charges and shorter stays.

Area of Science:

  • Pediatric hospital medicine
  • Health services research
  • Biostatistics

Background:

  • Over 40% of childhood deaths occur during hospitalization.
  • National-level data on end-of-life healthcare utilization in children is limited.

Purpose of the Study:

  • To characterize patterns in length of stay, total charges, and principal diagnoses for hospitalized children who die versus those who survive.
  • To analyze sociodemographic factors and hospital resource use linked to in-hospital mortality.

Main Methods:

  • Cross-sectional analysis of three years from the Nationwide Inpatient Sample (NIS) dataset.
  • Utilized a nationally representative sample of hospital discharges spanning a decade.
  • Examined sociodemographic characteristics and hospital resource utilization patterns.

Main Results:

  • In-hospital mortality was higher for infants under one year old compared to other age groups; newborns accounted for the largest number of deaths.
  • Transferred patients had a significantly higher mortality rate than non-transferred patients.
  • Decedents had longer lengths of stay and higher charges than survivors; uninsured decedents had lower charges and similar lengths of stay compared to survivors.

Conclusions:

  • Healthcare providers must recognize the elevated mortality risk in young children and those transferred between facilities.
  • Children without insurance may face higher mortality risks and require expanded services due to potential resource limitations.
  • Understanding these patterns is crucial for optimizing care and resource allocation for critically ill children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including: